Running discussion on SP, page-77006

I agree..we must not sell 24% to CATH until both the Zijin and Dathomir cases are decisively concluded. We'd be shooting ourselves in the foot.

NF mentioned the possibility that CATH may be willing to roll with a 9% sale, as long as they get firm assurances that they will have access to a significant proportion of our output (I remember 50% as mentioned). As long as these OT's have a finite time period of 3-5 years snd equitable I think that this would ne a reasonable outcome rather than risk losing our majority control through a 24% sale with ownership disputes outstanding.

it would of course limit the geographic expansion of our product sale base, at least temporarily, but given we are in an existential fight for our very existence I think that could be a problem for another day.